167 related articles for article (PubMed ID: 24943657)
1. Titer and product affect the distribution of gene expression after intraputaminal convection-enhanced delivery.
Emborg ME; Hurley SA; Joers V; Tromp do PM; Swanson CR; Ohshima-Hosoyama S; Bondarenko V; Cummisford K; Sonnemans M; Hermening S; Blits B; Alexander AL
Stereotact Funct Neurosurg; 2014; 92(3):182-94. PubMed ID: 24943657
[TBL] [Abstract][Full Text] [Related]
2. Pathways of infusate loss during convection-enhanced delivery into the putamen nucleus.
Brady ML; Raghavan R; Alexander A; Kubota K; Sillay K; Emborg ME
Stereotact Funct Neurosurg; 2013; 91(2):69-78. PubMed ID: 23344643
[TBL] [Abstract][Full Text] [Related]
3. Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys.
Johnston LC; Eberling J; Pivirotto P; Hadaczek P; Federoff HJ; Forsayeth J; Bankiewicz KS
Hum Gene Ther; 2009 May; 20(5):497-510. PubMed ID: 19203243
[TBL] [Abstract][Full Text] [Related]
4. Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease.
Richardson RM; Kells AP; Rosenbluth KH; Salegio EA; Fiandaca MS; Larson PS; Starr PA; Martin AJ; Lonser RR; Federoff HJ; Forsayeth JR; Bankiewicz KS
Mol Ther; 2011 Jun; 19(6):1048-57. PubMed ID: 21343917
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease.
Rocco MT; Akhter AS; Ehrlich DJ; Scott GC; Lungu C; Munjal V; Aquino A; Lonser RR; Fiandaca MS; Hallett M; Heiss JD; Bankiewicz KS
Mol Ther; 2022 Dec; 30(12):3632-3638. PubMed ID: 35957524
[TBL] [Abstract][Full Text] [Related]
6. Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys.
Su X; Kells AP; Huang EJ; Lee HS; Hadaczek P; Beyer J; Bringas J; Pivirotto P; Penticuff J; Eberling J; Federoff HJ; Forsayeth J; Bankiewicz KS
Hum Gene Ther; 2009 Dec; 20(12):1627-40. PubMed ID: 19671001
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Targeted Delivery of AAV5-GFP into the Cerebellum of Nonhuman Primates Following a Single Convection-Enhanced Delivery Infusion.
Salegio EA; Cukrov M; Lortz R; Green A; Lambert E; Copeland S; Gonzalez M; Stockinger DE; Yeung JM; Hwa GGC
Hum Gene Ther; 2022 Jan; 33(1-2):86-93. PubMed ID: 34779239
[TBL] [Abstract][Full Text] [Related]
8. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain.
Hadaczek P; Kohutnicka M; Krauze MT; Bringas J; Pivirotto P; Cunningham J; Bankiewicz K
Hum Gene Ther; 2006 Mar; 17(3):291-302. PubMed ID: 16544978
[TBL] [Abstract][Full Text] [Related]
9. Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity.
Luz M; Allen PC; Bringas J; Boiko C; Stockinger DE; Nikula KJ; Lewis O; Woolley M; Fibiger HC; Bankiewicz K; Mohr E
Arch Toxicol; 2018 Jul; 92(7):2353-2367. PubMed ID: 29785638
[TBL] [Abstract][Full Text] [Related]
10. Convection-enhanced delivery of MANF--volume of distribution analysis in porcine putamen and substantia nigra.
Barua NU; Bienemann AS; Woolley M; Wyatt MJ; Johnson D; Lewis O; Irving C; Pritchard G; Gill S
J Neurol Sci; 2015 Oct; 357(1-2):264-9. PubMed ID: 26276514
[TBL] [Abstract][Full Text] [Related]
11. Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.
Ai Y; Markesbery W; Zhang Z; Grondin R; Elseberry D; Gerhardt GA; Gash DM
J Comp Neurol; 2003 Jun; 461(2):250-61. PubMed ID: 12724841
[TBL] [Abstract][Full Text] [Related]
12. Continuous intranigral infusion is not associated with observable behavioral deficits or marked pathology: a preclinical safety study.
Grondin R; Ai Y; Hardy PA; Butt MT; Nelson BD; Lemmon JD; Bumcrot D; Gash DM; Gerhardt GA; Zhang Z
J Neurosurg; 2017 Apr; 126(4):1253-1262. PubMed ID: 27231974
[TBL] [Abstract][Full Text] [Related]
13. Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys.
Oiwa Y; Nakai K; Itakura T
Neurol Med Chir (Tokyo); 2006 Jun; 46(6):267-75; discussion 275-6. PubMed ID: 16794346
[TBL] [Abstract][Full Text] [Related]
14. Axonal transport of AAV9 in nonhuman primate brain.
Green F; Samaranch L; Zhang HS; Manning-Bog A; Meyer K; Forsayeth J; Bankiewicz KS
Gene Ther; 2016 Jun; 23(6):520-6. PubMed ID: 26953486
[TBL] [Abstract][Full Text] [Related]
15. Image-guided convection-enhanced delivery of GDNF protein into monkey putamen.
Gimenez F; Krauze MT; Valles F; Hadaczek P; Bringas J; Sharma N; Forsayeth J; Bankiewicz KS
Neuroimage; 2011 Jan; 54 Suppl 1():S189-95. PubMed ID: 20080195
[TBL] [Abstract][Full Text] [Related]
16. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ
Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the rat.
Foust KD; Flotte TR; Reier PJ; Mandel RJ
Hum Gene Ther; 2008 Jan; 19(1):71-82. PubMed ID: 18072858
[TBL] [Abstract][Full Text] [Related]
18. Differential transgene expression profiles in rat brain, using rAAV2/1 vectors with tetracycline-inducible and cytomegalovirus promoters.
Bockstael O; Chtarto A; Wakkinen J; Yang X; Melas C; Levivier M; Brotchi J; Tenenbaum L
Hum Gene Ther; 2008 Nov; 19(11):1293-305. PubMed ID: 19866492
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
[TBL] [Abstract][Full Text] [Related]
20. AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters.
Sanftner LM; Sommer JM; Suzuki BM; Smith PH; Vijay S; Vargas JA; Forsayeth JR; Cunningham J; Bankiewicz KS; Kao H; Bernal J; Pierce GF; Johnson KW
Exp Neurol; 2005 Aug; 194(2):476-83. PubMed ID: 16022872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
